Clinical stage pharma company PharmaKure is set to embark on a clinical trial of a combined drug for patients with mild cognitive impairment. PharmaKure has filed a Clinical Trial Application (CTA) with the Medicines and Healthcare Regulatory Agency (MHRA) in the United Kingdom to evaluate PK051.
ACG named as care partner for the patient support service, which works with patients and families in hospital settings
Rise in psychological pseudoscience is putting people at risk and could do 'more harm than good', new book warns
Meet the legal experts based in the leading firm's new Newcastle office
Widespread differences in metal levels within the brains of people with Huntington’s disease have been discovered through a new study. Elements including selenium (a metalloid), sodium, potassium, magnesium, calcium, iron, zinc, copper, and manganese, were studied in 11 parts of the brain.
The latest shortlist in the NR Times Awards has been unveiled, ahead of the awards ceremony next week
While new NICE recommendations on greater rehab for stroke survivors are welcomed, questions arise around lack of provision
The ten finalists have been announced ahead of next week's awards ceremony
Open letter raises concerns around lack of funding commitment behind ABI Strategy, and highlights need for action in Autumn Statement
Finalists revealed in the inaugural NR Times Awards, with awards ceremony set for next week
Other Aspect Health Media Titles
Copyright © 2025 Aspect Health Media Ltd
